This tunable nature of mTOR signaling in Treg cells may offer a therapeutic strategy to modulate Treg-cell responses to selectively alter the conventional T-cell responses in autoimmunity, infectious diseases, and cancer. This evidence concerns the gene MTOR and Autoimmunity.